Chemical compound
Pharmaceutical compound
Lometraline (INN ; developmental code name CP-14,368 ) is a drug and an aminotetralin derivative .[ 1] A structural modification of tricyclic neuroleptics , lometraline was originally patented by Pfizer as an antipsychotic , tranquilizer , and antiparkinsonian agent .[ 2] [ 3] However, it was instead later studied as a potential antidepressant and/or anxiolytic agent, though clinical studies revealed no psychoactivity at the doses used and further investigation was suspended.[ 1] [ 4] [ 5] Further experimental modifications of the chemical structure of lometraline resulted in the discovery of tametraline , a potent inhibitor of the reuptake of dopamine and norepinephrine , which in turn led to the discovery of the antidepressant sertraline , a selective serotonin reuptake inhibitor (SSRI).[ 6]
References
^ a b Park S, Gershon S, Angrist B, Floyd A (February 1972). "Evaluation of an aminotetraline, CP 14.368, as an antidepressant". Current Therapeutic Research, Clinical and Experimental . 14 (2): 65–70. PMID 4401233 .
^ Drake E (27 January 1994). Saunders pharmaceutical word book, 1994 . W.B. Saunders Co. ISBN 978-0-7216-5254-2 . Retrieved 27 April 2012 .
^ United States. Patent Office (1972). "Lometraline: tranquillizer, anti-parkinson agent". Official gazette of the United States Patent Office: Patents . The Office. Retrieved 27 April 2012 .
^ McMahon FG (1974). Psychopharmacological agents . Futura Pub. Co. ISBN 978-0-87993-052-3 . Retrieved 27 April 2012 .
^ Bayerische Julius-Maximilians-Universität Würzburg. Arbeitskreis für Schlafforschung (1973). The Nature of sleep. Die Natur des Schlafes. La nature du sommeil: International symposium, Würzburg, 23-26.9.1971 . G. Fischer. ISBN 978-3-437-10295-0 . Retrieved 27 April 2012 .
^ Koe BK , Harbert CA, Sarges R, Weissman A, Welch WM (2006). "Discovery of sertraline (Zoloft®)" . Archived from the original on 2014-12-30. Retrieved 2012-04-27 .